Human copper-containing amine oxidases in drug design and development

S Vakal, S Jalkanen, KM Dahlström, TA Salminen - Molecules, 2020 - mdpi.com
Two members of the copper-containing amine oxidase family are physiologically important
proteins:(1) Diamine oxidase (hDAO; AOC1) with a preference for diamines is involved in …

Dysregulation of SWI/SNF chromatin remodelers in NSCLC: its influence on cancer therapies including immunotherapy

Y Shi, DS Shin - Biomolecules, 2023 - mdpi.com
Lung cancer is the leading cause of cancer death worldwide. Molecularly targeted
therapeutics and immunotherapy revolutionized the clinical care of NSCLC patients …

A Worldwide Pharmacoepidemiologic Update on Drug‐Induced Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in the Era of Targeted Therapies

S Deshayes, C Dolladille, A Dumont… - Arthritis & …, 2022 - Wiley Online Library
Objective The literature supporting the role of a specific drug in the onset of drug‐induced
antineutrophil cytoplasmic antibody–associated vasculitis (AAV) mainly relies on case …

Hydralazine-induced antineutrophil cytoplasmic antibody-associated vasculitis with pulmonary–renal syndrome: a case report

A Al-Abdouh, AM Siyal, H Seid, A Bekele… - Journal of Medical Case …, 2020 - Springer
Background Hydralazine is a common vasodilator which has been used for the treatment of
hypertension and heart failure. Hydralazine can induce antineutrophil cytoplasmic antibody …

Cutaneous adverse drug reactions

T Bettuzzi, P Sanchez-Pena, B Lebrun-Vignes - Therapies, 2024 - Elsevier
Cutaneous adverse drug reactions (ADRs) represent a heterogeneous field including
various clinical patterns without specific features suggesting drug causality. Maculopapular …

[HTML][HTML] Hydralazine-induced antineutrophil cytoplasmic antibody-associated vasculitis: asymptomatic and renal-restricted presentation

W Tu, B Fayman, SC Ward, Y Mamoon… - The American Journal …, 2021 - ncbi.nlm.nih.gov
Objective: Rare disease Background: Hydralazine, a potent vasodilator widely used to treat
hypertension, has been implicated in an increasing number of cases of drug-induced …

Drug-induced cutaneous vasculitis and anticoagulant-related cutaneous adverse reactions: insights in pathogenesis, clinical presentation, and treatment

AK Guzman, Y Balagula - Clinics in Dermatology, 2020 - Elsevier
Drug-induced vasculitis and anticoagulant-related skin reactions are commonly
encountered in the inpatient and outpatient settings. The spectrum of clinical presentation is …

Overlapping syndromes: drug-induced vasculitis from hydralazine with positive antinuclear antibodies

L Kannan, UR Syeda - Clinical Medicine Insights: Case …, 2023 - journals.sagepub.com
Hydralazine is an antihypertensive medication that has been associated with drug-
associated autoimmune syndromes like interstitial lung disease, pauci-immune …

Seizures, renal failure and acute respiratory failure: not your typical case of Henoch-Schonlein purpura

S Bose, S Pathireddy, KM Baradhi… - BMJ Case Reports …, 2019 - casereports.bmj.com
A 30-year-old Caucasian woman with no prior medical history presented with pedal
oedema, arthralgias and abdominal pain with diarrhoea, following a respiratory infection …

[HTML][HTML] Hydralazine-induced antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis: a case report and literature review

D Alawneh, A Edrees - Cureus, 2022 - ncbi.nlm.nih.gov
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a disease that
typically presents with multiorgan involvement. It can be idiopathic and at times drug …